Chief Medical Officer’s letter regarding measles vaccination
On 15 April 2025 the Australian Department of Health and Aged Care Chief Medical Officer (CMO) Prof Anthony Lawler shared a message regarding the recent increase in confirmed cases of measles across Australia.
The CMO emphasised the critical role of vaccination in preventing measles. The full letter can be read here.
Following on from this letter, the CMO released an additional message to highlight state- and territory-funded measles programs that offer free protection to certain groups, on top of the NIP-funded groups; and the importance of checking patients’ vaccine history.
Visit your local health department’s immunisation website for more information.
Updated immunisation reference page: Translated 2025 influenza page
Translated versions of MVEC’s newly updated 2025 influenza reference page are now available. Access the reference in Vietnamese, Hindi and Simplified Chinese.
MVEC’s influenza reference page details recommendations for flu vaccination in 2025, including:
- influenza strains included in this year’s vaccines
- brands available by age and funding
- commonly asked questions.
Switch between languages using the dropdown box at the beginning of the page.
एमवीईसी: इन्फ्लुएंजा
Australian Immunisation Handbook: Influenza chapter updated
The Australian Immunisation Handbook chapter on influenza was updated on 7 April 2025 to reflect 2025 influenza vaccine information.
Immunisation Coalition: 9th Annual Immunisation Forum (AIF)
The Immunisation Coalition will host the 9वां Annual Immunisation Forum (AIF) hybrid event on Friday 13 June 2025 in Adelaide, immediately following CDIC 2025.
The meeting is tailored to GPs, practice nurses, specialists, pharmacists and other immunisation specialists.
For more information, including the program, and to register, visit the टीकाकरण गठबंधन का घटना पृष्ठ.
Immunisation Coalition: RSV Dinner Meeting
The Immunisation Coalition will be hosting an RSV Dinner Meeting at which leading experts will discuss:
- early learnings from the maternal vaccination and infant immunisation RSV programs
- how to increase vaccination rates
- where the focus should be for adults 60 years and over.
Location: Adelaide Convention Centre, North Terrace, Adelaide OR online
Date: Tuesday 10 June 2025
Learn more and register on the टीकाकरण गठबंधन का घटना पृष्ठ.
CDIC 2025: Earlybird registration closes 14 April 2025
Registration is open for the Communicable Diseases & Immunisation Conference (CDIC) 2025.
This year’s CDIC will be held in Adelaide from Tuesday 10 to Thursday 12 June. In addition to face-to-face registration, CDIC offers Plenary Hub registration.
Earlybird registration fees end at 11:59 pm AEST on Monday 14 April 2025.
Learn more and register on the CDIC 2025 website.
NCIRS: Recording of webinar – Triple protection: Vaccines for influenza, COVID‑19 and RSV in 2025
The टीकाकरण अनुसंधान और निगरानी के लिए राष्ट्रीय केंद्र (एनसीआईआरएस) has recently uploaded recordings of presentations from its webinar on influenza, COVID‑19 and RSV vaccines in 2025. The webinar featured a panel of immunisation experts who presented on a range of topics.
NCIRS: Triple protection webinar recordings
एमवीईसी: इन्फ्लुएंजा
एमवीईसी: कोविड-19
MVEC: RSV
New PAEDS data: Respiratory syncytial virus (RSV) and influenza
The Paediatric Active Enhanced Disease Surveillance (PAEDS) network is a hospital-based surveillance system for selected serious childhood conditions, including vaccine-preventable diseases.
PEADS is updated regularly with new information, and 2025 data is now available. Visit PAEDS: Paediatric RSV in Australia और PAEDS: Paediatric Influenza Australia for current data on RSV and influenza in Australia. Data is updated monthly.
MVEC: PAEDS (Paediatric Active Enhanced Disease Surveillance)
एमवीईसी: रेस्पिरेटरी सिंकाइटियल वायरस (आरएसवी)
एमवीईसी: इन्फ्लुएंजा
ATAGI statement on the administration of COVID-19 vaccines in 2025
Today, 27 March, the Australian Technical Advisory Group on Immunisation (ATAGI) released a statement with current guidelines for COVID-19 vaccination.
Vaccination is recommended every 6 months for those aged 75 years or over, and every 12 months for adults 65 to 74 years and adults aged 18 to 64 years with severe immunocompromise.
In addition to these recommendations, some groups are eligible to receive COVID-19 vaccinations and may choose to do so based on a benefit–risk assessment.
Find out more in the full ATAGI statement.
Updated immunisation reference page: Respiratory syncytial virus (RSV)
MVEC has recently updated its RSV reference page with a new FAQ addressing whether there is an increased risk of preterm birth associated with RSV vaccines in pregnancy.
Current data has not demonstrated a statistically significant risk of preterm birth associated with Abrysvo. A trial of a different RSV vaccine was halted due to a difference in the number of preterm births in the vaccine group compared with the placebo group.
Find MVEC’s detailed answer in the ‘Commonly asked questions’ section of the एमवीईसी: रेस्पिरेटरी सिंकाइटियल वायरस (आरएसवी) reference page, under the question ‘Is there an increased risk of preterm birth associated with RSV vaccine in pregnancy’.